Company profile: Yuhan
1.1 - Company Overview
Company description
- Provider of business development and partnership services in the pharmaceutical industry, focusing on exploring collaborative opportunities in targeted therapy, oncology immunotherapy, and metabolic diseases as the U.S. subsidiary of Yuhan Corporation.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Yuhan
Pharmalog
HQ: Germany
Website
- Description: Provider of clinical research services as a clinical research organization, conducting Phase I and Phase II–IV trials for pharmaceutical and biotechnology companies, as well as non-interventional (NIS) studies. Offers research programs, special trials including dermatological/cosmetic studies, and medical writing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pharmalog company profile →
AbbVie
HQ: United States
Website
- Description: Provider of contract development and manufacturing services for pharmaceutical companies across small and large molecules and biologics. Offerings include aseptic fill-finish of parenteral vials and prefilled syringes; biologics and antibody-drug conjugate manufacturing; API process optimization, tech transfer, and analytical development; turnkey ophthalmic filling and packaging; hot melt extrusion to improve API solubility and bioavailability; and microbial fermentation for API process development and commercial manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AbbVie company profile →
Synteract HCR
HQ: United States
Website
- Description: Provider of global full-service contract research organization support for biotechnology, medical device, and pharmaceutical companies across all phases of clinical development, delivering customized Phase I–IV services collaboratively and cost effectively.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Synteract HCR company profile →
Pro-Spectus
HQ: United States
Website
- Description: Provider of healthcare advisory services specializing in the pharmaceutical, medical device, and diagnostic healthcare industries, offering a Patient Access Program that enables patient and market access to therapies by optimizing the patient access journey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pro-Spectus company profile →
Creative Peptides
HQ: United States
Website
- Description: Provider of custom peptide synthesis and process development, specializing in bioactive peptides from small-scale research to large-scale clinical and commercial production. Offers peptide modifications (phosphorylation, glycosylation, lipidation), analysis, pharmaceutical peptide development support (formulation, regulatory compliance), GMP manufacturing for trials and commercial use, and catalog products, including protein glycosylation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Creative Peptides company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Yuhan
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Yuhan
2.2 - Growth funds investing in similar companies to Yuhan
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Yuhan
4.2 - Public trading comparable groups for Yuhan
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →